Danqing Miao

Title: Danqing Miao: Innovator in Fusion Protein Technology

Introduction

Danqing Miao is a prominent inventor based in Tianjin, China. She has made significant contributions to the field of biotechnology, particularly in the development of fusion proteins. Her innovative work has the potential to enhance vaccine efficacy, which is crucial in the fight against infectious diseases.

Latest Patents

Danqing Miao holds a patent for a fusion protein and its construction method and use. The patent describes a fusion method that combines a protein D and a Hin47 (Htra) protein. This fusion protein serves as a vehicle for a polysaccharide-protein conjugate vaccine, thereby increasing the immunogenicity of a polysaccharide antigen. This advancement could lead to more effective vaccines and improved public health outcomes.

Career Highlights

Miao is currently associated with CanSino Biologics Inc., a company known for its focus on innovative vaccine development. Her work at CanSino Biologics has positioned her as a key player in the biotechnology sector. With her expertise, she continues to contribute to groundbreaking research and development in vaccine technology.

Collaborations

Danqing Miao collaborates with notable colleagues, including Junqiang Li and Mingming Yang. These partnerships enhance the research environment and foster innovation within their projects.

Conclusion

Danqing Miao's contributions to fusion protein technology and vaccine development highlight her role as an influential inventor in the biotechnology field. Her work not only advances scientific knowledge but also has the potential to improve global health through more effective vaccines.